tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Ahu Demir, 9 are a BUY (90%), 1 are a HOLD (10%).
Analyst Ahu Demir, currently employed at LADENBURG, carries an average stock price target met ratio of 37.5% that have a potential upside of 37.13% achieved within 71 days. Previously, Ahu Demir worked at NOBLE CAPITAL.
Ahu Demir’s has documented 18 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on EVAX, Evaxion Biotech AS at 02-Apr-2024.
Analyst best performing recommendations are on ONTX (ONCONOVA THERAPEUTICS).
The best stock recommendation documented was for ONTX (ONCONOVA THERAPEUTICS) at 12/22/2020. The price target of $6.9 was fulfilled within 1 day with a profit of $0.47 (7.31%) receiving and performance score of 73.09.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 31-Oct-2022
$16
3 years 4 months 19 days ago
(31-Oct-2022)
0/1 (0%)
$12 (300.00%)
Buy
$1
$0.4 (66.67%)
$20
3 years 5 months 2 days ago
(20-Oct-2022)
1/2 (50%)
$4.66 (64.44%)
67
Buy Since 20-Dec-2021
3 years 7 months 6 days ago
(16-Aug-2022)
0/1 (0%)
$9.28 (106.42%)
Buy Since 20-Dec-2021
$12
$11.5 (2300.00%)
3 years 11 months 20 days ago
(30-Mar-2022)
0/2 (0%)
$8 (200.00%)
Buy Since 10-Jun-2020
$6
$5.5 (1100.00%)
$24
3 years 11 months 20 days ago
(30-Mar-2022)
0/2 (0%)
$2 (50.00%)
What Year was the first public recommendation made by Ahu Demir?
